NM_002863.5:c.1828-2delA
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PVS1_ModerateBP6_Very_StrongBA1
The NM_002863.5(PYGL):c.1828-2delA variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.46 ( 17685 hom., cov: 0)
Exomes 𝑓: 0.37 ( 107281 hom. )
Consequence
PYGL
NM_002863.5 splice_acceptor, intron
NM_002863.5 splice_acceptor, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Publications
16 publications found
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
- glycogen storage disease VIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.05581761 fraction of the gene. Cryptic splice site detected, with MaxEntScore 6.4, offset of 0 (no position change), new splice context is: gtttgaccttcttccccaAGgct. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
BP6
Variant 14-50911872-CT-C is Benign according to our data. Variant chr14-50911872-CT-C is described in ClinVar as Benign. ClinVar VariationId is 194627.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.649 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002863.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PYGL | TSL:1 MANE Select | c.1828-2delA | splice_acceptor intron | N/A | ENSP00000216392.7 | P06737-1 | |||
| PYGL | TSL:1 | c.1828-2delA | splice_acceptor intron | N/A | ENSP00000431657.1 | E9PK47 | |||
| PYGL | c.1843-2delA | splice_acceptor intron | N/A | ENSP00000544346.1 |
Frequencies
GnomAD3 genomes AF: 0.460 AC: 69868AN: 151864Hom.: 17649 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
69868
AN:
151864
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.441 AC: 110756AN: 251422 AF XY: 0.426 show subpopulations
GnomAD2 exomes
AF:
AC:
110756
AN:
251422
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.371 AC: 542589AN: 1461716Hom.: 107281 Cov.: 0 AF XY: 0.372 AC XY: 270277AN XY: 727164 show subpopulations
GnomAD4 exome
AF:
AC:
542589
AN:
1461716
Hom.:
Cov.:
0
AF XY:
AC XY:
270277
AN XY:
727164
show subpopulations
African (AFR)
AF:
AC:
22419
AN:
33478
American (AMR)
AF:
AC:
28627
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
9004
AN:
26136
East Asian (EAS)
AF:
AC:
26102
AN:
39700
South Asian (SAS)
AF:
AC:
38168
AN:
86248
European-Finnish (FIN)
AF:
AC:
19091
AN:
53406
Middle Eastern (MID)
AF:
AC:
2603
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
372531
AN:
1111868
Other (OTH)
AF:
AC:
24044
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
23232
46464
69697
92929
116161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
12306
24612
36918
49224
61530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.460 AC: 69959AN: 151982Hom.: 17685 Cov.: 0 AF XY: 0.464 AC XY: 34462AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
69959
AN:
151982
Hom.:
Cov.:
0
AF XY:
AC XY:
34462
AN XY:
74294
show subpopulations
African (AFR)
AF:
AC:
27164
AN:
41430
American (AMR)
AF:
AC:
8145
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1143
AN:
3472
East Asian (EAS)
AF:
AC:
3212
AN:
5158
South Asian (SAS)
AF:
AC:
2156
AN:
4820
European-Finnish (FIN)
AF:
AC:
3798
AN:
10560
Middle Eastern (MID)
AF:
AC:
141
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23037
AN:
67952
Other (OTH)
AF:
AC:
955
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1762
3523
5285
7046
8808
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1884
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
3
Glycogen storage disease, type VI (3)
-
-
3
not specified (3)
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.